These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 611842)

  • 1. [Aluminum poisoning by phosphate binders in kidney insufficiency].
    Fuchs C; Dorn D; Doht B; Freytag E; Fuchs CA; Henning HV; Scheler F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1313-5. PubMed ID: 611842
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis.
    Andreoli SP; Bergstein JM; Sherrard DJ
    N Engl J Med; 1984 Apr; 310(17):1079-84. PubMed ID: 6708989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide.
    Griswold WR; Reznik V; Mendoza SA; Trauner D; Alfrey AC
    Pediatrics; 1983 Jan; 71(1):56-8. PubMed ID: 6848980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iatrogenic aluminum osteopathy in a uremic infant].
    Koch H; Reich H; Franke D; Delling G
    Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.
    Moriniere P; Hocine C; Boudailliez B; Belbrik S; Renaud H; Westeel PF; Solal MC; Fournier A
    Kidney Int Suppl; 1989 Nov; 27():S133-5. PubMed ID: 2636648
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aluminum poisoning caused by the phosphate binder in a non-dialysed child with chronic renal insufficiency].
    Feldmann B; Färber D; Pontz BF
    Radiologe; 1992 Jul; 32(7):327-32. PubMed ID: 1509030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder.
    Malberti F; Surian M; Colussi G; Poggio F; Minoia C; Salvadeo A
    Kidney Int Suppl; 1988 Mar; 24():S184-5. PubMed ID: 3163047
    [No Abstract]   [Full Text] [Related]  

  • 8. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminium poisoning in uremic children].
    Hinojosa-Lezama M; Gordillo-Paniagua G
    Bol Med Hosp Infant Mex; 1986 Sep; 43(9):532-6. PubMed ID: 3790225
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum-aluminum in nondialyzed chronic uremic patients before and during treatment with aluminum-containing phosphate-binding gels.
    Brahm M
    Clin Nephrol; 1986 May; 25(5):231-5. PubMed ID: 3720033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum toxicity following administration of aluminum-based phosphate binders in 2 dogs with renal failure.
    Segev G; Bandt C; Francey T; Cowgill LD
    J Vet Intern Med; 2008; 22(6):1432-5. PubMed ID: 19000253
    [No Abstract]   [Full Text] [Related]  

  • 12. Antacid induction of phosphate depletion syndrome in renal failure.
    Abrams DE; Silcott RB; Terry R; Berne TV; Barbour BH
    West J Med; 1974 Feb; 120(2):157-60. PubMed ID: 4813797
    [No Abstract]   [Full Text] [Related]  

  • 13. Is serum aluminium monitoring useful in evaluating aluminium intoxication?
    Gilli P; Malacarne F; Fagioli F
    Lancet; 1983 Mar; 1(8325):656. PubMed ID: 6131339
    [No Abstract]   [Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F; Monnier N; Reveillaud RJ
    Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate binders in hyperphosphatemia of chronic renal failure.
    Wasan SM; Godley PJ
    DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
    [No Abstract]   [Full Text] [Related]  

  • 17. [How far should the serum concentration of inorganic phosphate be lowered in patients with chronic uremia?].
    Eigler J; Grabensee B; Henning HV
    Med Welt; 1982 Jan; 33(4):115-6. PubMed ID: 7062836
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute aluminum encephalopathy in an uremic patient.
    Campistol JM; Cases A; Botey A; Revert A
    Nephron; 1989; 51(1):103-6. PubMed ID: 2783763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous perforation of the colon in uremia with fatal outcome--due to aluminium hydroxide?].
    Shasha SM; Barzilai A; Chaimovitz C; Vinaver J; Better OS
    Harefuah; 1977 Feb; 92(4):168-9. PubMed ID: 849841
    [No Abstract]   [Full Text] [Related]  

  • 20. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.